4/A: CME Group Director William Shepard Amends Form 4 Filing to Correct Share Acquisition Details

William Shepard, a director at CME Group, amended his Form 4 filing to reflect an updated number of shares acquired through a dividend reinvestment plan.

Summary

• William Shepard, a director of CME Group, filed an amended Form 4 (Form 4/A) with the SEC.
• The amendment corrects the number of shares acquired on January 16, 2025, through a dividend reinvestment plan.
• The original Form 4, filed on January 17, 2025, was updated due to an adjustment made by the broker administering the plan.
• The corrected filing shows that Shepard indirectly owns 256,798.43 shares through a trust and directly owns 2,431.89 shares.
• The shares were purchased at a price of $227.96 per share.
• The amendment reflects the accurate number of securities held directly and indirectly following the purchase.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a minor discrepancy in a previous report, indicating a neutral to slightly positive sentiment due to transparency.

Industry Context

Form 4 filings are standard practice for company insiders (directors, officers, and 10% owners) to report transactions in their company's stock, providing transparency to the market.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for corporate insiders in the United States, ensuring transparency and preventing insider trading.
• Similar filings exist in other jurisdictions with comparable securities regulations, such as the UK's Disclosure and Transparency Rules and Canada's System for Electronic Disclosure by Insiders (SEDI).
• The level of detail required in Form 4 filings is generally consistent with global benchmarks for insider transaction reporting.

Stakeholder Impact

• The correction of the share acquisition details ensures accurate information for shareholders.
• The filing provides transparency regarding insider transactions, which can influence investor confidence.

Key Dates

Keywords

Form 4, CME Group, William Shepard, Dividend Reinvestment Plan, Share Acquisition, SEC Filing, Amendment